Showing results 56 to 75 of 102
< previous
next >
| Issue Date | Title | Author(s) |
| 2022-08-03 | Nanoparticulate drugs and vaccines: Breakthroughs and bottlenecks of repurposing in breast cancer. | Kumbhar, P; Kole, K; Khadake, V; Marale, P; Manjappa, A; Nadaf, S; Jadhav, R; Patil, A; Singh, SK; Dua, K; Jha, NK; Disouza, J; Patravale, V |
| 2022-12-31 | Nanotechnology-based drug delivery for the treatment of CNS disorders | Mittal, KR; Pharasi, N; Sarna, B; Singh, M; Rachana,; Haider, S; Singh, SK; Dua, K; Jha, SK; Dey, A; Ojha, S; Mani, S; Jha, NK |
| 2021-10 | Nanotechnology-based therapeutic formulations in the battle against animal coronaviruses: an update | Krishnan, S; Thirunavukarasu, A; Jha, NK; Gahtori, R; Roy, AS; Dholpuria, S; Kesari, KK; Singh, SK; Dua, K; Gupta, PK |
| 2004-01 | A novel Adaptive Fuzzy Logic Controller (A-FLC) to reduce retransmission and service roundtrip time for logical TCP channels over the Internet | Lin, WW; Wong, AK; Dillon, TS; Yang, L; Guo, M; Gao, GR; Jha, NK |
| - | Novel Nanostructured Lipid Carriers Co-Loaded with Mesalamine and Curcumin: Formulation, Optimization and In Vitro Evaluation | Awasthi, A; Kumar, B; Gulati, M; Vishwas, S; Corrie, L; Kaur, J; Khursheed, R; Muhammed, RA; Kala, D; Porwal, O; Babu, MR; Chaitanya, MVNL; Kumar, A; Pandey, NK; Dureja, H; Chellappan, DK; Jha, NK; Gupta, G; Prasher, P; Kumar, D; Dua, K; Singh, SK |
| 2022-02 | Nuclear factor-kappa B (NF-κB) inhibition as a therapeutic target for plant nutraceuticals in mitigating inflammatory lung diseases | Alharbi, KS; Afzal, O; almalki, WH; Kazmi, I; Javed Shaikh, MA; Thangavelu, L; Gulati, M; Singh, SK; Jha, NK; Gupta, PK; Chellappan, DK; Oliver, BG; Dua, K; Gupta, G |
| 2021-06 | Nuclear factor-kappa B and its role in inflammatory lung disease | Alharbi, KS; Fuloria, NK; Fuloria, S; Rahman, SB; Al-Malki, WH; Javed Shaikh, MA; Thangavelu, L; Singh, SK; Rama Raju, VS; Jha, NK; Chellappan, DK; Dua, K; Gupta, G |
| 2022-10-14 | Nutraceuticals and COVID-19: A mechanistic approach toward attenuating the disease complications. | Paudel, KR; Patel, V; Vishwas, S; Gupta, S; Sharma, S; Chan, Y; Jha, NK; Shrestha, J; Imran, M; Panth, N; Shukla, SD; Jha, SK; Devkota, HP; Warkiani, ME; Singh, SK; Ali, MK; Gupta, G; Chellappan, DK; Hansbro, PM; Dua, K |
| - | Nutraceuticals and mitochondrial oxidative stress: bridging the gap in the management of bronchial asthma | Allam, VSRR; Paudel, KR; Gupta, G; Singh, SK; Vishwas, S; Gulati, M; Gupta, S; Chaitanya, MVNL; Jha, NK; Gupta, PK; Patel, VK; Liu, G; Kamal, MA; Hansbro, PM; Oliver, BGG; Chellappan, DK; Dua, K |
| - | Nutraceuticals: unlocking newer paradigms in the mitigation of inflammatory lung diseases | Chan, Y; Raju Allam, VSR; Paudel, KR; Singh, SK; Gulati, M; Dhanasekaran, M; Gupta, PK; Jha, NK; Devkota, HP; Gupta, G; Hansbro, PM; Oliver, BGG; Chellappan, DK; Dua, K |
| 2022-01-01 | Occurrence and distribution of perfluoroalkyl acids in rivers: Impact and risk assessment | Verma, N; Rani, L; Rachmalla, M; Dua, K; Jha, NK |
| 2022-01-01 | Optimization Studies on Imatinib Mesylate Loaded Nanoliposomes Using Box-Behnken Design | Dahiya, M; Awasthi, R; Gupta, G; Singh, SK; Gulati, M; Jha, NK; Jha, SK; Sharma, A; Prasher, P; Anand, K; Chellappan, DK; Dua, K; Dureja, H |
| 2022-01-12 | Overcoming drug delivery barriers and challenges in topical therapy of atopic dermatitis: A nanotechnological perspective. | Hemrajani, C; Negi, P; Parashar, A; Gupta, G; Jha, NK; Singh, SK; Chellappan, DK; Dua, K |
| 2021-12-16 | Overcoming hydrolytic degradation challenges in topical delivery: Non-aqueous nano-emulsions. | Kadukkattil Ramanunny, A; Singh, SK; Wadhwa, S; Gulati, M; Kapoor, B; Khursheed, R; Kuppusamy, G; Dua, K; Dureja, H; Chellappan, DK; Jha, NK; Gupta, PK; Vishwas, S |
| 2020-08-06 | Perspectives and advancements in the design of nanomaterials for targeted cancer theranostics. | Tan, YY; Yap, PK; Xin Lim, GL; Mehta, M; Chan, Y; Ng, SW; Kapoor, DN; Negi, P; Anand, K; Singh, SK; Jha, NK; Lim, LC; Madheswaran, T; Satija, S; Gupta, G; Dua, K; Chellappan, DK |
| - | Phytomedicines Targeting Cancer Stem Cells: Therapeutic Opportunities and Prospects for Pharmaceutical Development | Gupta, PK; Saraff, M; Gahtori, R; Negi, N; Tripathi, SK; Kumar, J; Kumar, S; Aldhayan, SH; Dhanasekaran, S; Abomughaid, MM; Dua, K; Gundamaraju, R; Ojha, S; Ruokolainen, J; Jha, NK; Kesari, KK |
| 2022-01-03 | PREVENTIVE ROLE OF SAPINDUS SPECIES IN DIFFERENT NEUROLOGICAL AND METABOLIC DISORDERS | Rawat, S; Gupta, G; Mishra, A; Pathak, S; Thangavelu, L; Singh, SK; Jha, NK; Kumar, D; Negi, P; Kumar, AP; Chellappan, DK; Dua, K |
| 2021-10-15 | Protein and peptide delivery to lungs by using advanced targeted drug delivery. | Chellappan, DK; Prasher, P; Saravanan, V; Vern Yee, VS; Wen Chi, WC; Wong, JW; Wong, JK; Wong, JT; Wan, W; Chellian, J; Molugulu, N; Prabu, SL; Ibrahim, R; Darmarajan, T; Candasamy, M; Singh, PK; Mishra, V; Khurana, N; Shastri, MD; Satija, S; Zacconi, FC; Chakraborty, A; Mehta, M; Gupta, PK; Dureja, H; Gulati, M; Singh, SK; Gupta, G; Jha, NK; George Oliver, BG; Dua, K |
| 2022-02-23 | Re-establishing the comprehension of phytomedicine and nanomedicine in inflammation-mediated cancer signaling. | Jha, NK; Arfin, S; Jha, SK; Kar, R; Dey, A; Gundamaraju, R; Ashraf, GM; Gupta, PK; Dhanasekaran, S; Abomughaid, MM; Das, SS; Singh, SK; Dua, K; Roychoudhury, S; Kumar, D; Ruokolainen, J; Ojha, S; Kesari, KK |
| - | Recent Advances in Cardiac Tissue Engineering for the Management of Myocardium Infarction | Sharma, V; Dash, SK; Govarthanan, K; Gahtori, R; Negi, N; Barani, M; Tomar, R; Chakraborty, S; Mathapati, S; Bishi, DK; Negi, P; Dua, K; Singh, SK; Gundamaraju, R; Dey, A; Ruokolainen, J; Thakur, VK; Kesari, KK; Jha, NK; Gupta, PK; Ojha, S |
